You searched for: cancer
1 to 4 of 4 results
Show
results per page
Matched phrases in profile:
MPS and cancer prognosis, circulating fDNA, Sentinel Node biopsy trials Breast Cancer Audit and cancer registries… Is parathyroid hormone-related protein a sensitive serum marker in advanced breast cancer?… Whole Genome Sequencing in high-risk breast cancer patients.… Breast Cancer… University of Nottingham(UK) and Mayo Clinic (USA) Chairman, Foundation for Breast Cancer Care… Background: To compare already used serum markers in advanced breast cancer, namely erythrocyte…
Breast and Endocrine Surgeon, Mater Hospitals South Brisbane.
Previous Fellowships at University of Nottingham(UK) and Mayo Clinic (USA)
Chairman, Foundation for Breast Cancer Care
Senior Surgeon Breast Screen Qld Metro south Brisbane
Breast Cancer Quality Audit - >140,000 entries , identiying gaps in service delivery to Breast Cancer patients
Matched phrases in profile:
. Survivin and XIAP have emerged as attractive targets for cancer therapeutics. This project will… Vincristine pharmacodynamics and pharmacogenetics in children with cancer: A limited-sampling, population modelling approach… Life and health after childhood cancer: a national data linkage cohort study (Cancer Australia grant led by The University of Sydney)… Blood Cancers… local, national and international collaborative research across all childhood cancer types. A/Prof… Background: Vincristine is a key component of many childhood cancer treatment regimens…
Associate Professor Andy Moore is a Paediatric Oncologist and Director of Research at Children's Health Queensland Hospital & Health Service (CHQ). He is also Director of the Queensland Children's Tumour Bank, which is part of UQ's Child Health Research Centre. The Queensland Children's Tumour Bank …
Matched phrases in profile:
Can computers conceive the complexity of cancer to cure it? Using artificial intelligence technology in cancer modelling and drug discovery… Advancing Targeted Therapies for Metastatic Breast and Gynaecologic Cancers using RNA-based Therapeutics with Lipid Nanoparticle (LNP) Delivery System… BACKGROUND Cancer ranks as the second leading cause of death globally and Breast cancer (BC… Cancer Biology and Therapeutics… addressing cancer molecular mechanisms with the goal of developing novel cancer therapeutics and… , further complicated in the context of cancer research by the inherent heterogeneity and complexity of…
I am a Principal Investigator (PI) and a senior research officer (SRO) at Mater research – UQ with excellent clinical and research laboratory skills and expertise in conducting and analyzing laboratory assays and resolving complex research and clinical laboratory problems. I can describe myself as …
Matched phrases in profile:
A novel transcriptional signature identifies T-cell infiltration in high-risk paediatric cancer… , cancer immunotherapy and molecular oncology. She is undertaking a PhD in immunology studying natural… cancer. Childhood cancer is a leading cause of death and clinicians increasingly seek treatments that…
Dr Natacha Omer is a paediatic oncologist at the Queensland Children's Hospital in Brisbane. She is specialised in solid tumours, with a spacial interest in paediatric and adolescent sarcomas, cancer immunotherapy and molecular oncology. She is undertaking a PhD in immunology studying natural killer …
1 to 4 of 4 results